Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CCL13 modulators(Monocyte chemotactic protein 4 ligand modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Phase 1 | US | - | |
Immune System Diseases | Phase 1 | US | - | |
Infectious Diseases | Phase 1 | US | - | |
Inflammation | Phase 1 | US | - |